1
|
Gao H, Liu B, Zhu P, Zhang LJ, Wan CP, Rao GX, Mao ZW. Synthesis and Biological Evaluation of New Piperazine Substituted 3, 5-Diarylisoxazolines. Curr Org Synth 2019; 16:294-302. [DOI: 10.2174/1570179416666181203121031] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2018] [Revised: 10/22/2018] [Accepted: 11/24/2018] [Indexed: 01/08/2023]
Abstract
Aim and Objective:
Isoxazolines are an important class of nitrogen and oxygen-containing heterocycles,
which have gained much importance as the potential biological agents. In order to study structureactivity
relationships of isoxazolines, this work has been conducted.
Materials and Methods:
A series of new piperazine substituted 3, 5-diarylisoxazoline derivatives (6-31) were
designed and synthesized, and in vitro anti-inflammatory activity in lipopolysaccharide (LPS)-stimulated
RAW-264.7 macrophages and anticancer effect against a panel of human tumor cell lines (Hela, A549 and
SGC7901) by MTT assay were evaluated.
Results:
The substituents of the NH group of piperazine ring had an obvious influence on biological activities.
Especially, compounds 5, 7, 8, 10, 11, 13 and 27-showed good inhibitory effect on the generation of NO compared
to dexamethasone. Furthermore, derivatives 5, 6, 7, 8, 9, 13 and 26 were found to be potential selectively
anticancer activity on human tumor cell lines, which displayed better cytotoxic activity to positive control 5-
FU.
Conclusion:
Piperazine substituted 3, 5-diarylisoxazoline derivatives could be considered as new antiinflammatory
and anticancer agents.
Collapse
Affiliation(s)
- Hui Gao
- College of Pharmaceutical Science, Yunnan University of Traditional Chinese Medicine, Kunming 650500, China
| | - Bei Liu
- College of Pharmaceutical Science, Yunnan University of Traditional Chinese Medicine, Kunming 650500, China
| | - Ping Zhu
- College of Pharmaceutical Science, Yunnan University of Traditional Chinese Medicine, Kunming 650500, China
| | - Li-Jun Zhang
- College of Pharmaceutical Science, Yunnan University of Traditional Chinese Medicine, Kunming 650500, China
| | - Chun-Ping Wan
- Central Laboratory, The No.1 Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, Kunming 650021, China
| | - Gao-Xiong Rao
- College of Pharmaceutical Science, Yunnan University of Traditional Chinese Medicine, Kunming 650500, China
| | - Ze-Wei Mao
- College of Pharmaceutical Science, Yunnan University of Traditional Chinese Medicine, Kunming 650500, China
| |
Collapse
|